These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21310450)

  • 1. Specific expression of osteopontin and S100A6 in hepatocellular carcinoma.
    Hua Z; Chen J; Sun B; Zhao G; Zhang Y; Fong Y; Jia Z; Yao L
    Surgery; 2011 Jun; 149(6):783-91. PubMed ID: 21310450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
    Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
    Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.
    Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ
    Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression and clinical significance of chemokine receptor CXCR2 in hepatocellular carcinoma.
    Liu Z; Yang L; Xu J; Zhang X; Wang B
    J Surg Res; 2011 Apr; 166(2):241-6. PubMed ID: 20018298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and significance of minichromosome maintenance protein7 in hepatocellular carcinoma].
    Liu J; Yao SK; Yin F
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):55-6. PubMed ID: 18226346
    [No Abstract]   [Full Text] [Related]  

  • 7. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.
    Lee YC; Pan HW; Peng SY; Lai PL; Kuo WS; Ou YH; Hsu HC
    Eur J Cancer; 2007 Mar; 43(4):736-44. PubMed ID: 17267202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
    Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
    Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The expression and significance of minichromosome maintenance proteins 2 in hepatocellular carcinoma].
    Wang XL; Xiong ZF; Feng MH; Cao SQ; Xiong W
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):548-9. PubMed ID: 20678453
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
    Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
    Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
    J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on correlation of JAK/STAT signal pathway with progression and prognosis in hepatocellular carcinoma].
    Zhang B; Zhong DW; Wang QW; Miao XY; Dai WD; Liu C; Pan KH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):368-70, 373. PubMed ID: 20368117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
    Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
    Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MACC 1 as a marker for vascular invasive hepatocellular carcinoma.
    Shirahata A; Fan W; Sakuraba K; Yokomizo K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2011 Mar; 31(3):777-80. PubMed ID: 21498695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy.
    Wang FH; Yip YC; Zhang M; Vong HT; Chan KI; Wai KC; Wen JM
    J Clin Pathol; 2010 Jul; 63(7):599-603. PubMed ID: 20501450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
    Hsu HC; Cheng W; Lai PL
    Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.
    Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H
    Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
    Frau M; Biasi F; Feo F; Pascale RM
    Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.